Aristides Capital’s Organigram Holdings OGI Stock Holding History

Aristides Capital’s Portfolio OGI Stock Details OGI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-36,270	Closed	-$254K	–	266
2021 Q4	$254K	Buy	+36,270	New	+$308K	0.12%	176
2021 Q1	–	Sell	-35,531	Closed	-$189K	–	158
2020 Q4	$189K	Buy	+35,531	New	+$182K	0.06%	127

Other funds holding OGI

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Merlin Capital Newport, Rhode Island $33.5M AUM 36.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

IIM

Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aristides Capital's OGI Position: Q1 2022 in Review

Aristides Capital sold out of Organigram Holdings (OGI) in Q1 2022, closing a stake of 36,270 shares — an estimated $254K sold.

Aristides Capital first reported a position in OGI in Q4 2020 and held it in 2 quarters. The position peaked at $254K in Q4 2021. 130 funds tracked by Wall St. Rank hold OGI as of Q1 2022.

Aristides Capital reported no remaining Organigram Holdings position as of Q1 2022 after selling out during the quarter.
Aristides Capital sold 36,270 Organigram Holdings shares in Q1 2022, an estimated $254K.
Aristides Capital first reported a position in Organigram Holdings in Q4 2020 and held it in 2 quarters.
Aristides Capital's Organigram Holdings position peaked at $254K in Q4 2021.
130 funds tracked by Wall St. Rank held Organigram Holdings as of Q1 2022.

Based on Aristides Capital's 13F filing for Q1 2022, filed 16 May 2022.